fig1
Figure 1. Patient-reported effects of disease-specific treatment (ERT/SRT) on common GD signs and symptoms. T0 refers to the signs and symptoms reported by the respondents at the time that GD-specific treatment (ERT or SRT) was initiated. Tr refers to response data on the dates of completion of the questionnaires (DEC 2020 - FEB 2021). (A) Change in symptoms 1-7; (B) Change in symptoms 8-14.
